BeiGene: a Vast Opportunity Lies Ahead – But We Remain Cautious
BeiGene, a leader in China's novel pharmaceutical industry, recently received approval in Kuwait, Bahrain, and Qatar for its medication BRUKINSA (zanubrutinib). Previous contracts with major biopharma have produced substantial licensing income, but they did not lessen BeiGene's financial burden.
Jun 24, 2022 12:13 PM
HeyTea Bets on Coffee, Again
Coffee is a darling among Chinese youth.
Jun 22, 2022 10:25 PM
Internet Giant Tencent Dipped Its Toe Into Carbon Neutrality
Chinese internet giant Tencent released two energy sector products, ‘Tencent EnerLink’ and ‘Tencent EnerTwin’, showing its ambition to facilitate the connectivity and smartlization of the energy industry and promote carbon neutrality goals.
Jun 22, 2022 06:15 PM
AI-driven pharmaceutics Company Helixon Raise CNY 500 Mn in Series A Round
As one of the key players in computational biology, Helixon received recognition from the capital market for its innovation in machine learning algorithms and data acquisition technologies which reconstruct the drug development process and improve the efficiency of new drug development.
Jun 22, 2022 06:13 PM